Development of diabetes mellitus in living pancreas donors and recipients

Expert Review of Clinical Immunology

Volumn 7, Issue 4, 2011, Pages 543-551

  Gruessner, Rainer Wg ^a   Pugliese, Alberto ^b   Reijonen, Helena K ^c   Gruessner, Stephan ^a   Jie, Tun ^a   Desai, Chirag ^a   Sutherland, David Er ^d   Burke Iii, George W ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

diabetes mellitus; GAD 65; IA 2; islet cells; living donor; pancreas transplant; post transplant recurrence; twin

Indexed keywords

1A 2 ANTIBODY AUTOANTIGEN; AUTOANTIBODY; AUTOANTIGEN; AZATHIOPRINE; C PEPTIDE; CATECHOLAMINE; CD25 ANTIBODY; CYCLOSPORIN A; CYTOKERATIN 19; EXENDIN 4; GLUCAGON; GLUCOSE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HEMOGLOBIN A1C; HLA A ANTIGEN; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; IMMUNOREACTIVE INSULIN; INSULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROINSULIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

AORTOGRAPHY; BLOOD PRESSURE MEASUREMENT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL THERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DONOR SELECTION; DRUG WITHDRAWAL; ENDOCRINE PANCREAS FUNCTION TEST; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HLA MATCHING; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; KIDNEY TRANSPLANTATION; LIVING DONOR; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOZYGOTIC TWINS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PLASMAPHERESIS; RECURRENCE RISK; RETRANSPLANTATION; REVIEW; SURVIVAL RATE; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSION; INSULIN-SECRETING CELLS; LIVING DONORS; OBESITY; PANCREAS TRANSPLANTATION; PANCREATECTOMY; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK; TRANSPLANTATION;

EID: 79960910886     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.11.19     Document Type: Review

References (42)

1. Dean PG, Kudva YC, Larson TS et al. Posttransplant diabetes mellitus after pancreas transplantation. Am J Transplant. 8(1), 175-182 (2008)
2. Tyden G, Reinholt FP, Sundkvist G et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J. Med 335(12), 860-863 (1996) (Pubitemid 26304068)
3. Petruzzo P, Andreelli F, McGregor B et al. Evidence of recurrent type I diabetes following HLA-mismatched pancreas transplantation. Diabetes Metab. 26(3), 215-218 (2000) (Pubitemid 30435768)
4. Gruessner RWG. Living donor pancreas transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds.), Springer-Verlag, New York, NY, USA, 423-440 (2004)
5. Seaquist ER, Gruessner RWG. Selection and workup. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 385-389 (2008)
6. Gruessner RWG. Morbidity, mortality, and long-term outcome. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 398-400 (2008)
7. Kendall DM, Sutherland DER, Najarian JS et al. Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J. Med 322(13), 898-903 (1990) (Pubitemid 20108379)
8. Robertson RP. Endocrine function and metabolic outcomes in pancreas and islet transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 441-454 (2004)
9. Seaquist ER, Robertson RP. Effects of hemipancreatectomy on pancreatic a and b cell function in healthy human donors. J Clin Invest. 89(6), 1761-1766 (1992)
10. Seaquist ER, Pyzdrowski K, Moran A et al. Insulin-mediated and glucose-mediated glucose uptake following hemipancreatectomy in healthy human donors. Diabetologia 37(10), 1036-1043 (1994) (Pubitemid 24300461)
11. Seaquist ER, Kahn SE, Clark PM et al. Hyperproinsulinemia is associated with increased b cell demand after hemipancreatectomy in humans. J Clin Invest. 97(2), 455-460 (1996) (Pubitemid 26039410)
12. Robertson RP, Lanz KJ, Sutherland DER et al. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 73(5), 736-741 (2002) (Pubitemid 34260569)
13. Robertson RP, Sutherland DER, Seaquist ER et al. Glucagon, catecholamine, and symptom responses to hypoglycemia in living donors of pancreas segments. Diabetes 52(7), 1689-1694 (2003) (Pubitemid 36792458)
14. Gruessner RWG, Sutherland DER, Drangstveit MB et al. Pancreas transplants from living donors: short-and long-term outcome. Transplant Proc. 33(1-2), 819-820 (2001) (Pubitemid 32237636)
15. Butler AE, Janson J, Bonner-Weir S et al. b-cell deficit and increased b-cell apoptosis in humans with type 2 diabetes. Diabetes 52(1), 102 (2003)
16. Brubaker PL, Drucker DJ. Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145(6), 2653-2659 (2004) (Pubitemid 38686211)
17. Gruessner RWG. The identical twin transplant experience: recurrence of disease. In: Living Donor Organ Transplantation. Gruessner RWG, Benedetti E (Eds). McGraw-Hill, New York, NY, USA, 412-413 (2008)
18. Gruessner RWG. Immunology in pancreas transplantation -autoimmune reactivation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 393-397 (2004)
19. Sutherland DER, Sibley RK, Xu XZ et al. Twin-to-twin pancreas transplantation: Reversal and reenactment of the pathogenesis of Type I diabetes. Trans. Assoc. Am Phys. 97, 80-87 (1984)
20. Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants. Diabetes 38(1), 85-87 (1989) (Pubitemid 19029246)
21. Sibley RD, Sutherland DER, Goetz F et al. Recurrent diabetes mellitus in the pancreas iso-and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest. 53(2), 132-144 (1985) (Pubitemid 15049005)
22. Santamaria P, Nakhleh RE, Sutherland DER et al. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 41(1), 53-61 (1992)
23. Nakhleh RE, Gruessner RWG, Swanson PE et al. Pancreas transplant pathology. A morphologic, immunohistochemical, and electron microscopic comparison of allogenic grafts with rejection, syngenetic grafts, and chronic pancreatitis. Am J Surg. Pathol. 15(3), 246-256 (1991)
24. Gruessner RWG. Immunology in pancreas transplantation. In: Transplantation of the Pancreas. Gruessner RWG, Sutherland DER (Eds). Springer-Verlag, New York, NY, USA, 393-403 (2004)
25. Bosi E, Bottazzo GF, Secchi A et al. Islet cell autoimmunity in Type I diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 38(1), 82-84 (1989) (Pubitemid 19029245)
26. Dieterle D, Hierl FX, Gutt B et al. Insulin and islet autoantibodies after pancreas transplantation. Transpl Int. 18(12), 1361-1865 (2005)
27. Lohmann T, Klemm T, Geissler F et al. Islet cell-specific autoantibodies as potential markers for recurrence of autoimmune Type diabetes after simultaneous pancreas-kidney transplantation. Transplant Proc. 34(6), 2249-2250 (2002) (Pubitemid 35299733)
28. Sundkvist G, Tyden G, Karlsson FA et al. Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus. Diabetologia 41(12), 1532-1534 (1998) (Pubitemid 28551627)
29. Esmatjes E, Rodriguez-Villar C, Ricart MJ et al. Recurrence of immunological markers for Type I (insulin-dependent) diabetes mellitus in immunosuppressed patients after pancreas transplantation. Transplantation 66(1), 128-131 (1998) (Pubitemid 28341181)
30. Thivolet C, Abou-Mara S, Martin X et al. Serological markers of recurrent b cell destruction in diabetic patients undergoing pancreatic transplantation. Transplantation 69(1), 99-103 (2000) (Pubitemid 30062615)
31. Braghi S, Bonifacio E, Secchi A et al. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type I diabetes. Diabetes 49(2), 218-224 (2000) (Pubitemid 30071000)
32. Jaeger C, Hering B, Drybert T et al. Islet cell antibodies and glutamic acid decarboxylase antibodies in patients with insulin-dependent diabetes mellitus undergoing kidney and islet-after-kidney transplantation. Transplantation 62(3), 424-426 (1996) (Pubitemid 26277355)
33. Jaeger C, Hering BJ, Hatziagelaki E et al. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression. J Mol Med. 77(1), 45-48 (1999) (Pubitemid 29146181)
34. Stegall MD, Lafferty KJ, Kam I et al. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 61(8), 1272-1274 (1996) (Pubitemid 26134783)
35. Eisenbarth GS, Stegall M. Islet and pancreatic transplantation -autoimmunity and alloimmunity. N Engl J. Med 335(12), 888-890 (1996) (Pubitemid 26304075)
36. Vendrame F, Pileggi A, Laughlin E et al. Recurrence of Type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59(4), 947-957 (2010)
37. Martin-Pagola A, Sisino G, Allende G et al. Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with Type 1 diabetes and recurrence of autoimmunity. Diabetologia 51(10), 1803-1813 (2008)
38. Laughlin E, Burke G, Pugliese A et al. Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin Immunol. 128(1), 23-30 (2008)
39. Tanaka S, Kobayashi T, Nakanishi K et al. Evidence of primary b-cell destruction by T-cells and b-cell differentiation from pancreatic ductal cells in diabetes associated with active autoimmune chronic pancreatitis. Diabetes Care. 24(9), 1661-1667 (2001) (Pubitemid 33716466)
40. Wang GS, Rosenberg L, Scott FW. Tubular complexes as a source for islet neogenesis in the pancreas of diabetes-prone BB rats. Lab Invest. 85(5) 675-688 (2005) (Pubitemid 40675448)
41. Bottino R, Criscimanna A, Casu A et al. Recovery of endogenous b-cell function in nonhuman primates after chemical diabetes induction and islet transplantation. Diabetes 58(2), 442-447 (2009)
42. Jarchum I, Nichol L, Trucco M et al. Identification of novel IGRP epitopes targeted in Type 1 diabetes patients. Clin Immunol. 127(3), 359-365 (2008)